نتائج البحث 401-410 من 23103 لعملية البحث عن Treatment
... treatment (refractory). Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and ...
Treatment Of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) ... The present study is an open-label, randomized, controlled, two-arm multi-center ...
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...
... treatment) in Breast Cancer 1/2 genes (BRCA 1/2) and PALB2 associated HER2 ... SC nivolumab in-home treatment may be safe, tolerable and/or effective when ...
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...
... treatment in patients with recurrent grade 2 or 3 meningioma as measured by 6-month PFS rate. Intraoperative Contrast Enhanced Ultrasound for the ...
The primary purpose of this study is to evaluate the effectiveness of non-fusion surgical treatment of Spinal Deformity Correction in Adolescent Idiopathic ...
Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...
Ascorbic Acid And Chemotherapy For The Treatment Of Relapsed Or Refractory Lymphoma, CCUS, And Chronic Myelomonocytic Leukemia. Mankato, Minn., Rochester, Minn.
... treatment response. Personalized Neoantigen Peptide-Based Vaccine In Combination With Pembrolizumab For Treatment Of Advanced Solid Tumors. Jacksonville, Fla ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.